(Q43719825)

26 November 2017

Follow-up of plasma semicarbazide-sensitive amine oxidase activity and retinopathy in Type 2 diabetes mellitus (English)

1 reference

26 November 2017

1 reference

Grönvall-Nordquist JL

1

1 reference

26 November 2017

Bäcklund LB

2

1 reference

26 November 2017

Garpenstrand H

3

1 reference

26 November 2017

Ekblom J

4

1 reference

26 November 2017

Landin B

5

1 reference

26 November 2017

Yu PH

6

1 reference

26 November 2017

Oreland L

7

1 reference

26 November 2017

Rosenqvist U

8

1 reference

26 November 2017

language of work or name

1 reference

1 September 2001

1 reference

Journal of Diabetes and its Complications

26 November 2017

1 reference

26 November 2017

15

1 reference

26 November 2017

5

1 reference

26 November 2017

250-256

1 reference

Plasma semicarbazide-sensitive amine oxidase activity is elevated in diabetes mellitus and correlates with glycosylated haemoglobin

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2801%2900151-9

7 January 2021

Circulating semicarbazide-sensitive amine oxidase is raised both in type I (insulin-dependent), in type II (non-insulin-dependent) diabetes mellitus and even in childhood type I diabetes at first clinical diagnosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2801%2900151-9

7 January 2021

Plasma semicarbazide-sensitive amine oxidase is elevated in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2801%2900151-9

7 January 2021

Potential therapeutic value of drugs inhibiting semicarbazide-sensitive amine oxidase: vascular cytoprotection in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2801%2900151-9

7 January 2021

Elevated plasma semicarbazide-sensitive amine oxidase (SSAO) activity in Type 2 diabetes mellitus complicated by retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2801%2900151-9

7 January 2021

Photographic detection of retinopathy in insulin-treated diabetes. A population study in the city of Tartu, Estonia

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2801%2900151-9

7 January 2021

Comparisons of studies on diabetic complications hampered by differences in GHb measurements

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2801%2900151-9

7 January 2021

The enhanced daily excretion of urinary methylamine in rats treated with semicarbazide or hydralazine may be related to the inhibition of semicarbazide-sensitive amine oxidase activities

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2801%2900151-9

7 January 2021

MICRODETERMINATION OF MONOAMINE OXIDASE AND 5-HYDROXYTRYPTOPHAN DECARBOXYLASE ACTIVITIES IN NERVOUS TISSUES

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2801%2900151-9

7 January 2021

Elevated serum semicarbazide-sensitive amine oxidase activity in non-insulin-dependent diabetes mellitus: correlation with body mass index and serum triglyceride.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2801%2900151-9

7 January 2021

Serum monoamine oxidase (MAO) in diabetes mellitus and some other internal diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2801%2900151-9

7 January 2021

Vascular adhesion protein 1 (VAP-1) mediates lymphocyte subtype-specific, selectin-independent recognition of vascular endothelium in human lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2801%2900151-9

7 January 2021

Cloning of vascular adhesion protein 1 reveals a novel multifunctional adhesion molecule

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2801%2900151-9

7 January 2021

Physiological and pathological influences on serum monoamine oxidase level. Effect of age, sex, contraceptive steroids and diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2801%2900151-9

7 January 2021

Formation of formaldehyde from adrenaline in vivo; a potential risk factor for stress-related angiopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2801%2900151-9

7 January 2021

Aminoguanidine inhibits semicarbazide-sensitive amine oxidase activity: implications for advanced glycation and diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2801%2900151-9

7 January 2021

Cloning and sequencing of a copper-containing, topa quinone-containing monoamine oxidase from human placenta

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2801%2900151-9

7 January 2021

10.1016/S1056-8727(01)00151-9

Identifiers

DOI

1 reference

26 November 2017

1 reference